Key Insights

Highlights

Success Rate

89% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

4.7%

2 terminated out of 43 trials

Success Rate

88.9%

+2.4% vs benchmark

Late-Stage Pipeline

7%

3 trials in Phase 3/4

Results Transparency

25%

4 of 16 completed with results

Key Signals

4 with results89% success

Data Visualizations

Phase Distribution

33Total
Not Applicable (24)
P 1 (3)
P 2 (3)
P 3 (2)
P 4 (1)

Trial Status

Completed16
Recruiting10
Unknown8
Not Yet Recruiting4
Terminated2
Active Not Recruiting2

Trial Success Rate

88.9%

Benchmark: 86.5%

Based on 16 completed trials

Clinical Trials (43)

Showing 20 of 20 trials
NCT07251790Not ApplicableRecruiting

Optimising Breathing Support at Extubation in Very Preterm Infants: A Clinical Study

NCT07550218Not Yet Recruiting

Surfactant Administration Methods in Preterm Infants With RDS: A Swedish Cohort Study

NCT03700606Not ApplicableCompletedPrimary

Physiological Changes With High-Flow Nasal Cannula

NCT06554522Phase 4RecruitingPrimary

Pragmatic Evaluation of Respiratory Distress Syndrome Treatment in Africa

NCT07344714Recruiting

Predicting the Need for Prolonged Respiratory Support in Neonates Delivered in a Lower-Level NICU Setting

NCT07442669Not ApplicableNot Yet Recruiting

Utilization of Lung Ultrasound Score in Decision for Minimally Invasive Surfactant Administration

NCT03825835Not ApplicableRecruiting

30% or 60% Oxygen at Birth to Improve Neurodevelopmental Outcomes in Very Low Birthweight Infants

NCT07101419Not ApplicableNot Yet Recruiting

Speed of Lung Inflation During Ventilation of Extremely Preterm Infants

NCT05446389Not ApplicableTerminated

PAL to Improve Oral Feeding for Infants With Chronic Lung Disease

NCT07098910Not ApplicableRecruitingPrimary

Surfactant Therapy Via Supraglottic Airway to Preterm Neonates With RDS in Vietnam

NCT03969992Phase 2CompletedPrimary

A Dose-Ranging Study to Determine the Efficacy, Safety and Tolerability of AeroFact

NCT05898633Phase 1Active Not Recruiting

Recombinant Surfactant Protein D (rfhSP-D) to Prevent Neonatal Chronic Lung Disease

NCT05615428Completed

Fast Assessment of Surfactant Deficiency in Preterm Infants to Speed up Treatment - Validation Study

NCT04689386Not ApplicableCompleted

Effect of Chest Physiotherapy on the Development of Preterm Infants.

NCT04016246Phase 3Active Not RecruitingPrimary

Respiratory Effect of the LISA Method with Sedation by Propofol Versus Absence of Sedation.

NCT06557551Not ApplicableRecruiting

Prophylactic Surfactant by Thin Endotracheal Catheter for Preterm Infants At Birth: the ProTeCt Trial

NCT06642285Not ApplicableRecruiting

Effect of Implementing Evidence Based Practices on Prevention of Associated Nasal Pressure Injuries Among Preterm Neonates With Non-Invasive Respiratory Support

NCT05609877Not ApplicableRecruitingPrimary

The NONA-LISA Trial

NCT03558737Not ApplicableTerminated

Nasal High-frequency Jet Ventilation (nHFJV) Following Extubation in Preterm Infants

NCT03513640Completed

Risk Factors of Meconium Obstruction and Respiratory Distress Syndrome in Preterm Infants

Scroll to load more

Research Network

Activity Timeline